DK439576A - Fremgangsmade til pavisning af hepatitis-antigen og -antistoffer samt vaccine mod hepatitis - Google Patents

Fremgangsmade til pavisning af hepatitis-antigen og -antistoffer samt vaccine mod hepatitis

Info

Publication number
DK439576A
DK439576A DK439576A DK439576A DK439576A DK 439576 A DK439576 A DK 439576A DK 439576 A DK439576 A DK 439576A DK 439576 A DK439576 A DK 439576A DK 439576 A DK439576 A DK 439576A
Authority
DK
Denmark
Prior art keywords
hepatitis
antibodies
procedure
detection
vaccine against
Prior art date
Application number
DK439576A
Other languages
Danish (da)
English (en)
Inventor
E Shaw
Original Assignee
Ortho Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Diagnostics filed Critical Ortho Diagnostics
Publication of DK439576A publication Critical patent/DK439576A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK439576A 1975-10-01 1976-09-29 Fremgangsmade til pavisning af hepatitis-antigen og -antistoffer samt vaccine mod hepatitis DK439576A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/618,644 US4100267A (en) 1975-10-01 1975-10-01 Method of detecting hepatitis B core antigen and antibody

Publications (1)

Publication Number Publication Date
DK439576A true DK439576A (da) 1977-04-02

Family

ID=24478533

Family Applications (1)

Application Number Title Priority Date Filing Date
DK439576A DK439576A (da) 1975-10-01 1976-09-29 Fremgangsmade til pavisning af hepatitis-antigen og -antistoffer samt vaccine mod hepatitis

Country Status (10)

Country Link
US (1) US4100267A (de)
JP (1) JPS5244230A (de)
AU (1) AU1807776A (de)
BE (1) BE846822A (de)
DE (1) DE2644493A1 (de)
DK (1) DK439576A (de)
FR (1) FR2326205A1 (de)
NL (1) NL7610853A (de)
NO (1) NO763344L (de)
SE (1) SE7610839L (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241175A (en) * 1978-12-18 1980-12-23 Merck & Co., Inc. Assay for hepatitis B core antibody
US6268122B1 (en) 1978-12-22 2001-07-31 Biogen, Inc. Recombinant DNA molecules and their method of production
US4464474A (en) * 1980-07-09 1984-08-07 Connaught Laboratories Limited Non-A, non-B hepatitis assay and vaccine
US5866383A (en) * 1982-11-30 1999-02-02 The United States Of America As Represented By The Department Of Health And Human Services In vitro ligation of foreign DNA into large eukaryotic viruses
US4547367A (en) * 1983-12-20 1985-10-15 The United States Of America As Represented By The Department Of Health And Human Services Hepatitis B core antigen vaccine
US4547368A (en) * 1983-12-20 1985-10-15 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Hepatitis B core antigen vaccine made by recombinant DNA
US4752567A (en) * 1984-06-21 1988-06-21 Janssen Pharmaceutica N.V. Method of visualizing individual submicroscopic metal particles
GB8604985D0 (en) * 1986-02-28 1986-04-09 Unilever Plc Precipitated silicas
JPH085804B2 (ja) * 1988-04-28 1996-01-24 財団法人化学及血清療法研究所 Ａ型及びｂ型肝炎混合アジュバントワクチン
DE4422238C2 (de) * 1994-06-24 1996-05-30 Behringwerke Ag Verfahren zur Isolierung einer Antigenpräparation
CN1500140A (zh) * 2001-03-28 2004-05-26 上海晶泰生物技术有限公司 用于测试多种待分析物的装置及方法

Also Published As

Publication number Publication date
JPS5244230A (en) 1977-04-07
NO763344L (de) 1977-04-04
AU1807776A (en) 1978-04-06
US4100267A (en) 1978-07-11
NL7610853A (nl) 1977-04-05
FR2326205A1 (fr) 1977-04-29
SE7610839L (sv) 1977-04-02
DE2644493A1 (de) 1977-04-14
BE846822A (fr) 1977-03-30

Similar Documents

Publication Publication Date Title
DK149968C (da) Fremgangsmaade til immunkemisk maengdebestemmelse af et antigen
DK151398C (da) Apparat til immunologisk bestemmelse af antigener eller antistoffer og anvendelse af dette apparat
SE7506592L (sv) Forfarande for att bestemma antigener och antikroppar och foremal for anvendning dervid.
NL7614266A (nl) Roetbevattende pigmenten en werkwijze voor de bereiding daarvan.
NL7501215A (nl) Methode voor het aantonen en bepalen van een antigeen of antilichaam.
DK59778A (da) Fremgangsmaade til fremstilling af antigen og antistof
SE7613241L (sv) Serologiskt forfarande for bestemning av neisseria gonorrhoeae-antikroppar
DK145347C (da) Fremgangsmaade til rensning af hepatitis b antigen
SE7606789L (sv) Sett och anordning for noggrann avmetning av radioaktiv losningar
DK439576A (da) Fremgangsmade til pavisning af hepatitis-antigen og -antistoffer samt vaccine mod hepatitis
DK49479A (da) Fremgangsmaade til fremstilling af vaccine samt fremgangsmaade til fremstilling af et antisof
DK144395C (da) Fremgangsmaade og proevningssaet til proevning for tilstedevaerelsen af hepatitis b overfladeantigen i menneskeblod
SE7407139L (sv) Forfarande for pavisande av antikroppar
ZA761346B (en) Vaccine for active immunization containing hepatitis b surface antigen and associated antigen
NL7607958A (nl) Nieuw rabies virusvaccin en werkwijze ter bereiding daarvan.
DK255376A (da) Fremgangsmade til fremstilling af betonelementer samt apparat til udovelse af fremgangsmaden
DK28077A (da) Fremgangsmade til ekstraktion af antigen og anvendelse deraf samt produkter fremstillet deraf
FR2325934A1 (fr) Methode de detection de la presence d'un antigene associe a l'hepatite
SE7604235L (sv) Forfarande och anordning for permanent polymerisering av skivformade piezoelektriska kroppar
DK480376A (da) Disubstituerede phenolethere af 3-amino-2-hydroxypropan fremgangsmader til deres fremstilling samt deres anvendelser
DK145676A (da) Fremgangsmade til kemisk modificering af proteinstoffer
SE435742B (sv) Forfarande for drift av forbrenningsmotor samt forbrenningsmotor herfor
NL7504587A (nl) Cellulose-entcopolymeer alsmede werkwijze voor het bereiden daarvan.
NL7609533A (nl) Werkwijze en inrichting voor het detecteren van antilichamen en antigenen.
NL7601651A (nl) Azopigmenten en werkwijze voor het bereiden ervan.